blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3170840

EP3170840 - ANTIBODIES TO M-CSF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.09.2019
Database last updated on 12.11.2024
FormerThe patent has been granted
Status updated on  12.10.2018
FormerGrant of patent is intended
Status updated on  11.09.2018
FormerRequest for examination was made
Status updated on  27.07.2018
FormerGrant of patent is intended
Status updated on  05.03.2018
FormerRequest for examination was made
Status updated on  10.11.2017
FormerThe application has been published
Status updated on  21.04.2017
Most recent event   Tooltip16.07.2021Lapse of the patent in a contracting state
New state(s): HU		published on 18.08.2021  [2021/33]
Applicant(s)For all designated states
Warner-Lambert Company LLC
201 Tabor Road
Morris Plains NJ 07950 / US
For all designated states
Amgen Fremont Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2017/21]
Inventor(s)01 / BEDIAN, Vahe
25 Karal Drive
Framingham, MA 01701 / US
02 / DEVALARAJA, Madhav Narasimha
690 Trego Circle
Ann Arbor, MI 48103 / US
03 / LOW, Joseph Edwin
4259 Fairway Drive
Ann Arbor, MI 48103 / US
04 / MOBLEY, James Leslie
10195 Covington
Brighton, MI 48114 / US
05 / KELLERMANN, Sirid-Aimee
1000 Alamanor Avenue
Menlo Park, CA 94025 / US
06 / FOLTZ, Ian
2108 Knightswood Place
Burnaby, British Columbia V5A4B9 / CA
07 / HAAK-FRENDSCHO, Mary
8472 Willow Place
Newark, CA 94560 / US
 [2018/09]
Former [2017/21]01 / BEDIAN, Vahe
3 Frog Hollow Road
East Lyme, CT 06333 / US
02 / DEVALARAJA, Madhav Narasimha
690 Trego Circle
Ann Arbor, MI 48103 / US
03 / LOW, Joseph Edwin
4259 Fairway Drive
Ann Arbor, MI 48103 / US
04 / MOBLEY, James Leslie
10195 Covington
Brighton, MI 48114 / US
05 / KELLERMANN, Sirid-Aimee
1000 Alamanor Avenue
Menlo Park, CA 94025 / US
06 / FOLTZ, Ian
2108 Knightswood Place
Burnaby, British Columbia V5A4B9 / CA
07 / HAAK-FRENDSCHO, Mary
8472 Willow Place
Newark, CA 94560 / US
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2017/21]
Application number, filing date16201588.709.09.2004
[2017/21]
Priority number, dateUS20030502163P10.09.2003         Original published format: US 502163 P
[2017/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3170840
Date:24.05.2017
Language:EN
[2017/21]
Type: B1 Patent specification 
No.:EP3170840
Date:14.11.2018
Language:EN
[2018/46]
Search report(s)(Supplementary) European search report - dispatched on:EP19.04.2017
ClassificationIPC:C07K16/24, A61K39/395, A61P19/02, A61P35/00, A61P37/00, C12N5/10
[2017/21]
CPC:
A61K38/193 (EP,NO,US); C07K16/18 (KR); C07K16/243 (NO,US);
A61K39/395 (NO,US); A61P1/00 (EP); A61P1/04 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/04 (EP);
A61P17/06 (EP); A61P17/16 (EP); A61P19/00 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P33/06 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P37/00 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P39/02 (EP); A61P43/00 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07K16/24 (EP,KR,NO,US);
G06Q30/02 (EP,US); G06Q30/0601 (EP,US); G06Q40/04 (EP,US);
G06Q50/12 (EP,US); A61K2039/505 (EP,NO,US); C07K2317/14 (NO,US);
C07K2317/21 (EP,NO,US); C07K2317/56 (EP,NO,US); C07K2317/565 (NO,US);
C07K2317/73 (EP,NO,US); C07K2317/76 (EP,NO,US); C07K2317/92 (EP,NO,US);
Y02A50/30 (EP,NO,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/50]
Former [2017/21]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL27.10.2017
HR27.10.2017
LT27.10.2017
LV27.10.2017
MK27.10.2017
TitleGerman:ANTIKÖRPER GEGEN M-CSF[2017/21]
English:ANTIBODIES TO M-CSF[2017/21]
French:ANTICORPS DIRIGÉS CONTRE LE M-CSF[2017/21]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure01.12.2016Date on which the examining division has become responsible
27.10.2017Examination requested  [2017/50]
06.03.2018Communication of intention to grant the patent
16.07.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
16.07.2018Fee for grant paid
16.07.2018Fee for publishing/printing paid
10.09.2018Information about intention to grant a patent
10.09.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04809712.5  / EP1670825
Opposition(s)15.08.2019No opposition filed within time limit [2019/43]
Fees paidRenewal fee
23.03.2017Renewal fee patent year 03
23.03.2017Renewal fee patent year 04
23.03.2017Renewal fee patent year 05
23.03.2017Renewal fee patent year 06
23.03.2017Renewal fee patent year 07
23.03.2017Renewal fee patent year 08
23.03.2017Renewal fee patent year 09
23.03.2017Renewal fee patent year 10
23.03.2017Renewal fee patent year 11
23.03.2017Renewal fee patent year 12
23.03.2017Renewal fee patent year 13
27.09.2017Renewal fee patent year 14
27.09.2018Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.09.2004
AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
FI14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
[2021/33]
Former [2021/26]AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
FI14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2020/25]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
FI14.11.2018
MC14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2020/17]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
FI14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2019/50]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
FI14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2019/40]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
FI14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SK14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2019/37]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
FI14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2019/35]AT14.11.2018
CZ14.11.2018
DK14.11.2018
FI14.11.2018
NL14.11.2018
PL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2019/34]AT14.11.2018
DK14.11.2018
FI14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2019/26]AT14.11.2018
FI14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
PT14.03.2019
Former [2019/24]AT14.11.2018
FI14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
Former [2019/23]AT14.11.2018
FI14.11.2018
NL14.11.2018
BG14.02.2019
Former [2019/22]FI14.11.2018
BG14.02.2019
Former [2019/21]FI14.11.2018
Documents cited:Search[A]WO9009400  (CETUS CORP [US]);
 [A]WO9824893  (ABGENIX INC [US]);
by applicantUS4399216
 US4510245
 US4634665
 EP0216846
 EP0256055
 US4740461
 EP0323997
 US4912040
 WO9005719
 US4959455
 US4968615
 WO9110741
 WO9117271
 WO9201047
 WO9209690
 WO9215679
 US5151510
 WO9218619
 WO9220791
 US5168062
 US5179017
 WO9301288
 WO9306213
 US5223409
 WO9402602
 EP0606046
 WO9519970
 WO9521613
 US5545807
 US5545806
 WO9627583
 WO9633172
 US5569825
 WO9634096
 WO9633735
 US5587458
 US5591669
 US5612205
 WO9713760
 US5625126
 US5633425
 EP0780386
 WO9722596
 US5643763
 US5661016
 WO9732856
 WO9802434
 WO9802438
 WO9802437
 WO9803516
 US5721367
 WO9807697
 WO9814451
 US5741957
 WO9816654
 US5747498
 US5750172
 US5756687
 WO9824893
 US5770429
 WO9830566
 US5789650
 US5789215
 WO9833768
 US5792783
 WO9834918
 WO9834915
 US5814318
 US5827690
 US5834504
 WO9850433
 WO9850356
 WO9852976
 WO9854093
 US5861510
 US5863949
 US5877305
 WO9910349
 US5883113
 US5886020
 WO9916755
 WO9924440
 WO9929667
 US5916771
 WO9935146
 WO9935132
 EP0931788
 US5939598
 WO9945031
 US5959177
 WO9953049
 WO9952910
 WO9952889
 US5985615
 US5994619
 WO9961422
 US5998209
 WO0009560
 US6046037
 US6075181
 WO0034317
 WO0037504
 US6091001
 US6114598
 US6130364
 US6150584
 US6162963
 US6284764
 US6417429
 US6465449
 US6517529
 WO03048731
 EP19890303964
 EP19970304971
 WO1998IB01113
 EP19990302232
 WO1999IB00797
 GB19990012961
 US19990148464
 EP19990308617
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.